2-methoxyestradiol has been researched along with Adenocarcinoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Choromanska, A; Kulbacka, J; Saczko, J; Waszkiewicz, M | 1 |
| Fan, J; Fu, D; Guo, Z; Jin, C; Li, J; Lin, Q; Yao, L; Zou, X | 1 |
| Joubert, A; Lafanechère, L; Martinez, A; Mqoco, T; Prudent, R; Theron, A; Vieira, W; Visagie, M | 1 |
| Bar, J; Bednarz-Misa, I; Choromańska, A; Dubińska-Magiera, M; Kulbacka, J; Marcinkowska, A; Rembiałkowska, N; Saczko, J | 1 |
| Fecková, B; Ilkovičová, L; Kello, M; Kimáková, P; Sačková, V; Solár, P; Solárová, Z | 1 |
| Bedolla, R; Ganapathy, M; Ghosh, R; Jianping, X; Kumar, AP; Olumi, AF; Schoolfield, J; Troyer, DA; Yeh, IT; Zhang, X | 1 |
| Florczak, U; Kehlbach, R; Peter Rodemann, H; Toulany, M | 1 |
| Joubert, AM; Marais, S; Stander, BA; Vorster, CJ | 1 |
| Banerjee, S; Banerjee, SK; Dhar, G; Dhar, K; Haque, I; Kambhampati, S; Majumder, M; Mehta, S; Ray, G; Vanveldhuizen, PJ | 1 |
| Hsieh, DP; Li, LA; Lin, CJ; Lin, S | 1 |
| Banerjee, S; Banerjee, SK; Borrego-Diaz, E; Burns, D; Das, A; Haque, I; Jha, S; Kambhampati, S; Rajewski, RA; Tanol, M; Van Veldhuizen, PJ | 1 |
| Arevalo, N; Garcia, GE; Kraft, SL; Kumar, AP; Lucia, MS; Slaga, TJ; Strange, R; Wisniewski, HG | 1 |
| Adachi, M; Hareyama, M; Imai, K; Shinomura, Y; Yoshioka, K; Zhao, S; Zou, H | 1 |
| Amir, S; Mabjeesh, NJ; Matzkin, H; Shefler, A | 1 |
14 other study(ies) available for 2-methoxyestradiol and Adenocarcinoma
| Article | Year |
|---|---|
The photodynamic reaction with IR-775 cyanine combined with 2-methoxyestradiol in ovarian (SKOV-3) and human breast adenocarcinoma (MDA MB-231) cell lines.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Mercaptoethanol; Ovary; Photochemotherapy; Photosensitizing Agents | 2022 |
The roles of ID-1 in human pancreatic ductal adenocarcinoma and the therapeutic effects of 2-methoxyestradiol.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Inhibitor of Differentiation Protein 1; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Retrospective Studies | 2018 |
Sulphamoylated 2-methoxyestradiol analogues induce apoptosis in adenocarcinoma cell lines.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Shape; Cytochromes c; Drug Screening Assays, Antitumor; Enzyme Activation; Estradiol; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Microtubules; Protein Multimerization; Sulfonamides; Tubulin; Tubulin Modulators | 2013 |
Oxidative modification induced by photodynamic therapy with Photofrin®II and 2-methoxyestradiol in human ovarian clear carcinoma (OvBH-1) and human breast adenocarcinoma (MCF-7) cells.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cytoskeleton; Dihematoporphyrin Ether; Estradiol; Female; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Immunohistochemistry; Nitric Oxide Synthase Type II; Ovarian Neoplasms; Oxidation-Reduction; Photochemotherapy | 2015 |
Photoactivated hypericin increases the expression of SOD-2 and makes MCF-7 cells resistant to photodynamic therapy.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Anthracenes; Breast Neoplasms; Cell Line, Tumor; Estradiol; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Light; Perylene; Photochemotherapy; Photosensitizing Agents; RNA, Messenger; Superoxide Dismutase; Up-Regulation | 2017 |
Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Animals; CASP8 and FADD-Like Apoptosis Regulating Protein; Chromatin Immunoprecipitation; Disease Models, Animal; Estradiol; Fas-Associated Death Domain Protein; Humans; Immunoblotting; Immunoenzyme Techniques; Immunoprecipitation; Male; Mice; Mice, Transgenic; Promoter Regions, Genetic; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Sp1 Transcription Factor; Sp3 Transcription Factor; Transfection; Tubulin Modulators; Tumor Cells, Cultured | 2009 |
2-Methoxyestradiol-induced radiosensitization is independent of SOD but depends on inhibition of Akt and DNA-PKcs activities.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Apoptosis; Blotting, Western; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Damage; DNA-Activated Protein Kinase; Enzyme Activation; Estradiol; Humans; Lung Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Radiation Dosage; Radiation Tolerance; Radiation, Ionizing; Sensitivity and Specificity; Superoxide Dismutase | 2009 |
In vitro effects of 2-methoxyestradiol on morphology, cell cycle progression, cell death and gene expression changes in the tumorigenic MCF-7 breast epithelial cell line.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Caspase 3; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Shape; Cyclin B1; Cytochromes c; Estradiol; Female; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotide Array Sequence Analysis; Reactive Oxygen Species; Receptors, Estrogen; Vacuoles | 2010 |
2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Animals; Antineoplastic Agents; Barrett Esophagus; beta Catenin; Cadherins; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; Esophageal Neoplasms; Estradiol; Female; Humans; Male; Mice; Mice, Nude; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
ERα phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of lung adenocarcinoma cells.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Estradiol; Estrogen Receptor alpha; Estrogens; Estrogens, Catechol; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Nude; Ovariectomy; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Estradiol; Humans; Mice; Prodrugs; Xenograft Model Antitumor Assays | 2013 |
2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Animals; Cell Adhesion Molecules; Cell Line, Tumor; Diet; Disease Models, Animal; Estradiol; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms | 2006 |
2-methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun NH2-terminal kinase activation.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Animals; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Combined Modality Therapy; DNA Damage; Estradiol; Histones; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Nude; Microscopy, Confocal; Phosphorylation; Radiation-Sensitizing Agents; Radiation, Ionizing; Transfection; Xenograft Model Antitumor Assays | 2006 |
Potentiation of 2-methoxyestradiol-induced cytotoxicity by blocking endothelin A receptor in prostate cancer cells.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coculture Techniques; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Endothelin Receptor Antagonists; Estradiol; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Osteoblasts; Peptides, Cyclic; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger | 2008 |